Drugs that contain Alendronate Sodium

1. Drug name - BINOSTO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7964212 ASCEND THERAPS US Effervescent compositions comprising phosphonates and methods related thereto
Mar, 2023

(5 months from now)

US7488496 ASCEND THERAPS US Effervescent compositions comprising bisphosphonates and methods related thereto
Aug, 2023

(10 months from now)

EP1490024A1 ASCEND THERAPS US Effervescent Compositions Comprising Alendronate
Mar, 2023

(5 months from now)

EP2277503B1 ASCEND THERAPS US Effervescent Compositions Comprising Bisphosphonates
Mar, 2023

(5 months from now)

EP1490024B1 ASCEND THERAPS US Effervescent Compositions Comprising Alendronate
Mar, 2023

(5 months from now)

EP2277503A1 ASCEND THERAPS US Effervescent Compositions Comprising Bisphosphonates
Mar, 2023

(5 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9592195 ASCEND THERAPS US Stable effervescent bisphosphonate formulations with rapid solubilization characteristics Dec, 2031

(9 years from now)

Treatment: NA

Dosage: TABLET, EFFERVESCENT;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 70MG BASE TABLET, EFFERVESCENT;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.